Mind Medicine股票討論區

$Mind Medicine(MNMD.US)$ Mind Medicine Presents New Studies At ISPOR 2024 Showing Growing Burden And Impact Of Generalized Anxiety Disorder In The U.S.
Benzinga· just
GAD Diagnosis Increases Healthcare Costs and Decreases Work Productivity and Health-Related Quality of Life-
-People with Undiagnosed GAD Incur Even Higher Total Healthcare Costs than those Diagnosed with GAD-
-Comprehensive Analyses of GAD Disease Burden in the US Conducted by MindMed; Company is Investigating New Treatments...

$Mind Medicine(MNMD.US)$
NEWS
MindMed Reports First Quarter 2024 Financial Results and Business Updates
MindMed received Breakthrough Therapy Designation (BTD) from the FDA for MM120 in the treatment of GAD in adults, after positive Phase 2b results showing statistically significant activity through 12 weeks.
The Company has a strong financial position with $252.3 million in cash and cash equivalents as of March 31, 2024, sufficient to fund operations into 2026.
MindMed is on track to begin its ...

$Mind Medicine(MNMD.US)$ MindMed to voluntarily delist from CBOE Canada

$Mind Medicine(MNMD.US)$ this thing is great for options today!!!

$Mind Medicine(MNMD.US)$ buy pullback

$Mind Medicine(MNMD.US)$
bought position at 2.60🧠 said it was going to 17.0+ by end of the year. Its half way 💎
now my $Cybin(CYBN.US)$ and $ATAI Life Sciences(ATAI.US)$  are setting up for take off also. 🚀

$Mind Medicine(MNMD.US)$  
Women's Day I hope for flowers 🌺

$Mind Medicine(MNMD.US)$ Looks like they are going to park it at the 10 option expiration next week.

$Mind Medicine(MNMD.US)$ next lvl 11.76 and hopefully 12.33